Nome |
# |
Histopathological And Immunohistochemical Prognostic Factors In High-Grade Non-Endometrioid Carcinomas Of The Endometrium (Hg-Necs). Is It Possible To Identify Sub-Groups At Increased Risk?, file e268c4ce-0351-a6b7-e053-3a05fe0adea1
|
201
|
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis, file e268c4c7-68d3-a6b7-e053-3a05fe0adea1
|
165
|
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation, file e268c4ca-7e6b-a6b7-e053-3a05fe0adea1
|
136
|
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More, file e268c4ca-1d2b-a6b7-e053-3a05fe0adea1
|
127
|
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression, file e268c4ca-314f-a6b7-e053-3a05fe0adea1
|
127
|
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma, file e268c4ca-ba0d-a6b7-e053-3a05fe0adea1
|
123
|
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis, file e268c4ca-feb0-a6b7-e053-3a05fe0adea1
|
123
|
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis, file e268c4c7-91f3-a6b7-e053-3a05fe0adea1
|
122
|
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression, file e268c4ca-4577-a6b7-e053-3a05fe0adea1
|
122
|
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells, file e268c4c9-b9e0-a6b7-e053-3a05fe0adea1
|
121
|
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis, file e268c4ca-514d-a6b7-e053-3a05fe0adea1
|
98
|
Harnessing NK Cells for Cancer Treatment, file e268c4cb-cd90-a6b7-e053-3a05fe0adea1
|
98
|
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization, file e268c4ca-4318-a6b7-e053-3a05fe0adea1
|
97
|
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer, file e268c4cb-5fce-a6b7-e053-3a05fe0adea1
|
92
|
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis, file e268c4cb-4b8a-a6b7-e053-3a05fe0adea1
|
91
|
Features of Memory-Like and PD-1+ Human NK Cell Subsets, file e268c4cb-639b-a6b7-e053-3a05fe0adea1
|
85
|
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor, file e268c4cb-12aa-a6b7-e053-3a05fe0adea1
|
83
|
Teaching histology and anatomy online during the Covid-19 pandemic, file e268c4ce-3ded-a6b7-e053-3a05fe0adea1
|
80
|
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy, file e268c4cc-28d5-a6b7-e053-3a05fe0adea1
|
79
|
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands, file e268c4ca-18b3-a6b7-e053-3a05fe0adea1
|
75
|
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML, file e268c4cc-3c35-a6b7-e053-3a05fe0adea1
|
75
|
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content., file e268c4ca-1f01-a6b7-e053-3a05fe0adea1
|
70
|
Editorial: NK Cell Subsets in Health and Disease: New Developments, file e268c4cb-12ad-a6b7-e053-3a05fe0adea1
|
70
|
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses, file e268c4cb-2568-a6b7-e053-3a05fe0adea1
|
65
|
Cognate HLA absence in trans diminishes human NK cell education, file e268c4ca-7e70-a6b7-e053-3a05fe0adea1
|
58
|
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer, file e268c4cc-8f8c-a6b7-e053-3a05fe0adea1
|
55
|
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles, file e268c4cb-b802-a6b7-e053-3a05fe0adea1
|
45
|
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection, file e268c4ce-769c-a6b7-e053-3a05fe0adea1
|
24
|
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua, file e268c4ca-7799-a6b7-e053-3a05fe0adea1
|
8
|
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells, file e268c4ce-5545-a6b7-e053-3a05fe0adea1
|
7
|
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape, file e268c4ca-28d5-a6b7-e053-3a05fe0adea1
|
6
|
Female Malignancies and Immunotherapy: What's New?, file e268c4cc-c84e-a6b7-e053-3a05fe0adea1
|
6
|
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes, file e268c4cd-65e1-a6b7-e053-3a05fe0adea1
|
6
|
New Insights into Endometrial Cancer, file e268c4cd-d192-a6b7-e053-3a05fe0adea1
|
6
|
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file e268c4ce-349a-a6b7-e053-3a05fe0adea1
|
6
|
NK Cell-Based Immunotherapy in Colorectal Cancer, file 6addda51-cd56-4086-a887-e2447c93f8e3
|
5
|
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art, file ca788364-9e07-432c-a462-501212598b44
|
5
|
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway, file e268c4ca-0c6d-a6b7-e053-3a05fe0adea1
|
5
|
Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications, file 46cadd9d-f7aa-4fbf-97f8-8c025a134d60
|
4
|
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file 90274659-2248-4db2-a2d9-8e3628c61b91
|
4
|
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing, file f8942382-091d-4fbd-a3e6-0a766cfaeb6c
|
4
|
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers, file 0ba6e954-089c-4580-9b3f-6a7d1c0ed104
|
3
|
NK cells to cure cancer, file e268c4cb-12a1-a6b7-e053-3a05fe0adea1
|
3
|
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions, file e268c4ce-24c4-a6b7-e053-3a05fe0adea1
|
3
|
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1, file 354ff5da-54f5-4923-bb79-75261fe74f21
|
2
|
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia, file a6bf9400-9f3a-487e-8856-6adb0f202ef8
|
2
|
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways, file e268c4ca-43ac-a6b7-e053-3a05fe0adea1
|
2
|
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components, file e268c4ca-4851-a6b7-e053-3a05fe0adea1
|
2
|
Markers and function of human NK cells in normal and pathological conditions, file e268c4cb-12af-a6b7-e053-3a05fe0adea1
|
2
|
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma, file e268c4cc-a96f-a6b7-e053-3a05fe0adea1
|
2
|
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more, file 2671522b-88cf-4e05-8ae4-d3e959860106
|
1
|
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy, file e268c4cb-55a5-a6b7-e053-3a05fe0adea1
|
1
|
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry, file e268c4cd-1b84-a6b7-e053-3a05fe0adea1
|
1
|
Natural killer cell impairment in ovarian clear cell carcinoma, file e268c4cd-1b87-a6b7-e053-3a05fe0adea1
|
1
|
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment, file e268c4ce-2667-a6b7-e053-3a05fe0adea1
|
1
|
AMPHIOXUS NEUROGLIA: MOLECULAR CHARACTERIZATION AND EVIDENCE FOR EARLY COMPARTMENTALIZATION OF THE DEVELOPING NERVE CORD, file f83e33aa-246f-4bd4-8f74-efb021fa7b86
|
1
|
Totale |
2.806 |